Acadia Pharmaceuticals reported $0 in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
ALKERMES ALKS:US USD 290.9M 633K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Aptinyx Inc APTX:US USD 24.71M 211K
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Bristol Myers Squibb BMY:US USD 36.97B 141M
Cytokinetics CYTK:US USD 609.73M 411.31M
Eisai 4523:JP JPY 84.91B 7M
Eli Lilly And LLY:US USD 14.14B 548.2M
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
Marinus Pharmaceuticals MRNS:US USD 70.78M 430K
Moderna Inc MRNA:US USD 922M 281M
Ptc Therapeutics PTCT:US USD 981.61M 165K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M
YTE INCY:US USD 30.48M 681K